Ureteral mullerian carcinosarcoma (mixed mullerian tumor) associated with endometriosis occurring in a patient with a concentrated soy isoflavones supplementation

article OA: closed CC0 ⤵ 16 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-11

This case report describes a ureteral mullerian carcinosarcoma arising in endometriosis in a 75-year-old woman on concentrated soy isoflavones, suggesting a potential role for phytoestrogens in malignant transformation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text

The paper reports a rare case of a 75-year-old woman who developed a ureteral malignant mixed Mullerian tumor (mullerian carcinosarcoma) arising in florid endometriosis foci. The patient had prior hysterectomy and bilateral salpingo-oophorectomy for extensive endometriosis and had taken concentrated soy isoflavone phytoestrogen supplementation (72 mg/day) for 5 years. The authors state this is the first reported ureteral mullerian carcinosarcoma arising in endometriosis after extensive phytoestrogen supplementation, and they note that concentrated phytoestrogens may play a role in endometriosis maintenance and malignant transformation. This paper is centrally about endometriosis—specifically, it describes ureteral mullerian carcinosarcoma arising in endometriosis after concentrated soy isoflavone supplementation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 6,016 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Malignant transformation and particularly malignant mixed mullerian tumor arising in extragenital endometriosis is extremely rare and occurs in the majority of cases after estrogen replacement therapy. We present a case of a 75-year-old woman who developed a ureteral malignant mullerian carcinosarcoma in a context of florid endometriosis. The patient had a history of total hysterectomy with bilateral salpingo-oophorectomy 30 years earlier for extensive endometriosis. Since 5 years, the patient has been on phytoestrogen supplementation consisting of 72 mg/day of superconcentrated soy isoflavones. This is the first case of ureteral mullerian carcinosarcoma arising in endometriosis foci after extensive phytoestrogen supplementation. Our data suggest that phytoestrogens at least in concentrated form may play a role not only in maintenance of endometriosis but also in its malignant transformation. Given the extraordinary popularity and availability of these dietary supplements, several studies are indispensable regarding their safety particularly in women with extensive endometriosis. Similar content being viewed by others

References

Antonelli A, Simeone C, Frego E, Minimi G, Bianchi U, Cunico SC (2004) Surgical treatment of ureteral obstruction from endometriosis: our experience with thirteen cases. Int Urogynecol J Pelvic Floor Dysfunct 15:407–412 Booth C, Zahn CM, McBroom J, Maxwell GI (2004) Retroperitoneal mullerian carcinosarcoma associated with endometriosis: a case report. Gynecol Oncol 93:546–549 Brunson GL, Barclay DL, Sanders M, Araoz CA (1988) Malignant extraovarian endometriosis: two case reports and review of the literature. Gynecol Oncol 30:123–130 Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, Tamura M, Langoi D, Deb S (2005) Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 57:359–383 Burton JL, Wells M (2002) The effect of phytoestrogens on the female genital tract. J Clin Pathol 55:401–407 Chang HY, Changchien CC, Chen HH, Lin H, Huang CC (2005) Extrauterine mullerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature. Int J Gynecol Cancer 15:361–365 Chumas JC, Thanning L, Mann WJ (1986) Malignant mixed mullerian tumor arising in extragenital endometriosis: report of a case and review of the literature. Gynecol Oncol 23:227–233 Comiter CV (2002) Endometriosis of the urinary tract. Urol Clin North Am 29:625–635 Cotroneo MS, Lamartiniere CA (2001) Pharmacologic, but not dietary, genistein supports endometriosis in a rat model. Toxicol Sci 61:68–75 Donnez J, Nisolle M, Squifflet J (2002) Ureteral endometriosis: a complication of rectovaginal endometriotic (adenomyotic) nodules. Fertil Steril 77:32–37 Frohlich EP, Koller AB, van Blerk PJ, Margolius KA (1988) Adenocarcinoma from endometriosis causing urinary tract obstruction in a patient on oestrogen replacement therapy after hysterectomy. A case report. S Afr Med J 74:638–639 Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN (1997) Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146:294–306 Hasiuk AS, Petersen RO, Hanjani P, Griffin TD (1984) Extragenital malignant mixed Mullerian tumor. Case report and review of the literature. Am J Clin Pathol 81:102–105 Jimenez RE, Tiguert R, Hurley P, An T, Grignon DJ, Lawrence D, Triest J (2000) Unilateral hydronephrosis resulting from intraluminal obstruction of the ureter by adenosquamous endometrioid carcinoma arising from disseminated endometriosis. Urology 56:331 Johnson EB, Muto MG, Yanushpolsky EH, Mutter GL (2001) Phytoestrogen supplementation and endometrial cancer. Obstet Gynecol 98:947–950 Leiserowitz GS, Gumbs JL, Oi R, Dalrymple JL, Smith LH, Ryn J, Scudder S, Russell AH (2003) Endometriosis-related malignancies. Int J Gynecol Cancer 13:466–471 Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA (2004) Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 12:1559–1567 Nezhat C, Nezhat F, Nezhat C, Nasserbakht F, Rosati M, Seidman DS (1996) Urinary tract endometriosis treated by laparoscopy. Fertil Steril 66:920–924 Salerno MG, Masciullo V, Naldini A, Zannoni GF, Vellone V, Scambia G (2005) Endometrioid adenocarcinoma with squamous differentiation arising from ureteral endometriosis in a patient with no history of gonadal endometriosis. Gynecol Oncol 99(3):749–752 Seidman JD (1996) Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol 15:1–9 Shook TE, Nyberg LM (1988) Endometriosis of the urinary tract. Urology 31:1–6 Staar S, Richter DU, Makovitzky J, Briese V, Bergemann C (2005) Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ER alpha- and ER beta-mRNA and protein expression. Anticancer Res 25:1713–1718 Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ (2001) Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 20:133–139 Zanetta GM, Webb MJ, Li H, Keeney GL (2000) Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 79:18–22 Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Noel, JC., Anaf, V., Fayt, I. et al. Ureteral mullerian carcinosarcoma (mixed mullerian tumor) associated with endometriosis occurring in a patient with a concentrated soy isoflavones supplementation. Arch Gynecol Obstet 274, 389–392 (2006). https://doi.org/10.1007/s00404-006-0188-1 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-006-0188-1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Carcinosarcoma Endometriosis Mixed Tumor, Mullerian Ureteral Neoplasms Uterine Diseases Aged Carcinosarcoma Carcinosarcoma Cell Transformation, Neoplastic Dietary Supplements Endometriosis Female Humans Isoflavones Isoflavones Mixed Tumor, Mullerian Mixed Tumor, Mullerian Soybean Proteins Soybean Proteins Ureteral Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Cited by (16)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:12.369988+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK